1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cellular Therapy (CT) Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Stem Cell
1.2.3 Non-Stem Cell
1.3 Market by Application
1.3.1 Global Cellular Therapy (CT) Market Share by Application: 2018 VS 2022 VS 2029
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Cellular Therapy (CT) Market Perspective (2018-2029)
2.2 Cellular Therapy (CT) Growth Trends by Region
2.2.1 Cellular Therapy (CT) Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Cellular Therapy (CT) Historic Market Size by Region (2018-2023)
2.2.3 Cellular Therapy (CT) Forecasted Market Size by Region (2024-2029)
2.3 Cellular Therapy (CT) Market Dynamics
2.3.1 Cellular Therapy (CT) Industry Trends
2.3.2 Cellular Therapy (CT) Market Drivers
2.3.3 Cellular Therapy (CT) Market Challenges
2.3.4 Cellular Therapy (CT) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cellular Therapy (CT) Players by Revenue
3.1.1 Global Top Cellular Therapy (CT) Players by Revenue (2018-2023)
3.1.2 Global Cellular Therapy (CT) Revenue Market Share by Players (2018-2023)
3.2 Global Cellular Therapy (CT) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Cellular Therapy (CT) Revenue
3.4 Global Cellular Therapy (CT) Market Concentration Ratio
3.4.1 Global Cellular Therapy (CT) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cellular Therapy (CT) Revenue in 2022
3.5 Cellular Therapy (CT) Key Players Head office and Area Served
3.6 Key Players Cellular Therapy (CT) Product Solution and Service
3.7 Date of Enter into Cellular Therapy (CT) Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Cellular Therapy (CT) Breakdown Data by Type
4.1 Global Cellular Therapy (CT) Historic Market Size by Type (2018-2023)
4.2 Global Cellular Therapy (CT) Forecasted Market Size by Type (2024-2029)
5 Cellular Therapy (CT) Breakdown Data by Application
5.1 Global Cellular Therapy (CT) Historic Market Size by Application (2018-2023)
5.2 Global Cellular Therapy (CT) Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Cellular Therapy (CT) Market Size (2018-2029)
6.2 North America Cellular Therapy (CT) Market Size by Country (2018-2023)
6.3 North America Cellular Therapy (CT) Market Size by Country (2024-2029)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Cellular Therapy (CT) Market Size (2018-2029)
7.2 Europe Cellular Therapy (CT) Market Size by Country (2018-2023)
7.3 Europe Cellular Therapy (CT) Market Size by Country (2024-2029)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cellular Therapy (CT) Market Size (2018-2029)
8.2 Asia-Pacific Cellular Therapy (CT) Market Size by Country (2018-2023)
8.3 Asia-Pacific Cellular Therapy (CT) Market Size by Country (2024-2029)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Cellular Therapy (CT) Market Size (2018-2029)
9.2 Latin America Cellular Therapy (CT) Market Size by Country (2018-2023)
9.3 Latin America Cellular Therapy (CT) Market Size by Country (2024-2029)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cellular Therapy (CT) Market Size (2018-2029)
10.2 Middle East & Africa Cellular Therapy (CT) Market Size by Country (2018-2023)
10.3 Middle East & Africa Cellular Therapy (CT) Market Size by Country (2024-2029)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Gilead Sciences
11.1.1 Gilead Sciences Company Detail
11.1.2 Gilead Sciences Business Overview
11.1.3 Gilead Sciences Cellular Therapy (CT) Introduction
11.1.4 Gilead Sciences Revenue in Cellular Therapy (CT) Business (2018-2023)
11.1.5 Gilead Sciences Recent Development
11.2 Novartis
11.2.1 Novartis Company Detail
11.2.2 Novartis Business Overview
11.2.3 Novartis Cellular Therapy (CT) Introduction
11.2.4 Novartis Revenue in Cellular Therapy (CT) Business (2018-2023)
11.2.5 Novartis Recent Development
11.3 Osiris
11.3.1 Osiris Company Detail
11.3.2 Osiris Business Overview
11.3.3 Osiris Cellular Therapy (CT) Introduction
11.3.4 Osiris Revenue in Cellular Therapy (CT) Business (2018-2023)
11.3.5 Osiris Recent Development
11.4 Vericel Corporation
11.4.1 Vericel Corporation Company Detail
11.4.2 Vericel Corporation Business Overview
11.4.3 Vericel Corporation Cellular Therapy (CT) Introduction
11.4.4 Vericel Corporation Revenue in Cellular Therapy (CT) Business (2018-2023)
11.4.5 Vericel Corporation Recent Development
11.5 Vcanbio
11.5.1 Vcanbio Company Detail
11.5.2 Vcanbio Business Overview
11.5.3 Vcanbio Cellular Therapy (CT) Introduction
11.5.4 Vcanbio Revenue in Cellular Therapy (CT) Business (2018-2023)
11.5.5 Vcanbio Recent Development
11.6 Fujifilm Cellular Dynamics
11.6.1 Fujifilm Cellular Dynamics Company Detail
11.6.2 Fujifilm Cellular Dynamics Business Overview
11.6.3 Fujifilm Cellular Dynamics Cellular Therapy (CT) Introduction
11.6.4 Fujifilm Cellular Dynamics Revenue in Cellular Therapy (CT) Business (2018-2023)
11.6.5 Fujifilm Cellular Dynamics Recent Development
11.7 JCR Pharmaceuticals
11.7.1 JCR Pharmaceuticals Company Detail
11.7.2 JCR Pharmaceuticals Business Overview
11.7.3 JCR Pharmaceuticals Cellular Therapy (CT) Introduction
11.7.4 JCR Pharmaceuticals Revenue in Cellular Therapy (CT) Business (2018-2023)
11.7.5 JCR Pharmaceuticals Recent Development
11.8 Beike Biotechnology
11.8.1 Beike Biotechnology Company Detail
11.8.2 Beike Biotechnology Business Overview
11.8.3 Beike Biotechnology Cellular Therapy (CT) Introduction
11.8.4 Beike Biotechnology Revenue in Cellular Therapy (CT) Business (2018-2023)
11.8.5 Beike Biotechnology Recent Development
11.9 Golden Meditech
11.9.1 Golden Meditech Company Detail
11.9.2 Golden Meditech Business Overview
11.9.3 Golden Meditech Cellular Therapy (CT) Introduction
11.9.4 Golden Meditech Revenue in Cellular Therapy (CT) Business (2018-2023)
11.9.5 Golden Meditech Recent Development
11.10 Guanhao Biotech
11.10.1 Guanhao Biotech Company Detail
11.10.2 Guanhao Biotech Business Overview
11.10.3 Guanhao Biotech Cellular Therapy (CT) Introduction
11.10.4 Guanhao Biotech Revenue in Cellular Therapy (CT) Business (2018-2023)
11.10.5 Guanhao Biotech Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
